Clinical polygenic risk score testing for common cancers 

Antegenes provides innovative genetic tests for medical professionals, utilizing polygenic risk score (PRS) technology.

The tests assess an individual’s genetic risk for common cancers, including breast (AnteBC), prostate (AntePC), colorectal (AnteCRC), and skin melanoma (AnteMEL).

  • Guidance for the clinical use of the breast cancer polygenic risk score testing
  • Whitepaper - Breast cancer polygenic risk score test AnteBC
  • Test description - Breast cancer polygenic risk score test AnteBC
  • Polygenic risk score tests for common cancers

Get in touch

Reach out to our dedicated team of healthcare professionals and discover solutions that prioritise your patients health and well-being

"*" indicates required fields

This field is for validation purposes and should be left unchanged.